The recent success of some coronavirus vaccines in late-stage clinical trials has inched us closer to the end of the pandemic — a glimmer of hope in a long year of living with the virus. Now, the U.S. Food and Drug Administration is gearing up to consider emergency use authorization for Pfizer and BioNTech’s COVID-19 […]
